Cyber Letters Caution Foreign Firms Against Drug Claims for Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA has added a section to its "cyber letters" intended specifically for online foreign firms selling unapproved drug products that notes the items "may not be approved for marketing in this country.
You may also be interested in...
Focus Group Testing For Health Claim Consumer Perception Advised By CSPI
FDA should use focus groups to determine whether consumers understand or are misled by health claims on foods and dietary supplements, according to comments submitted to FDA June 4 by the Center for Science in the Public Interest
Focus Group Testing For Health Claim Consumer Perception Advised By CSPI
FDA should use focus groups to determine whether consumers understand or are misled by health claims on foods and dietary supplements, according to comments submitted to FDA June 4 by the Center for Science in the Public Interest
Focus Group Testing For Health Claim Consumer Perception Advised By CSPI
FDA should use focus groups to determine whether consumers understand or are misled by health claims on foods and dietary supplements, according to comments submitted to FDA June 4 by the Center for Science in the Public Interest